Bonify Cannabis Products Available to Medical Cannabis Patients via Patient Choice
WINNIPEG, MB – August 14, 2020 – Bonify, a Winnipeg-based licensed producer of high-quality cannabis, is pleased to announce that its products are now available to medical cannabis patients via Patient Choice, a newly launched online sales platform. Patient Choice provides flexibility and freedom to Canada’s medical cannabis patients by offering a wide range of cannabis products from a selection of Canadian licensed producers, including Bonify. The platform provides convenience to medical cannabis patients to try different products without having to re-register with different producers.
Pierre Morris, Bonify’s CEO states, “Since inception, Bonify has held a deep commitment to serve the Canadian medical cannabis community. In choosing the Patient Choice platform for our products, we believe that medical cannabis patients’ needs are served better than being locked into a single producer. We are proud to offer our products to patients through Patient Choice and are confident that many will opt for Bonify products due to their quality and value.”
Bonify will offer a limited selection of products and strains at launch, with plans to introduce a wider selection of strains and products this summer. For more information and to access the Patient Choice platform, please visit: https://www.patient-choice.com.
Bonify is a privately-owned Canadian licensed producer of adult-use recreational and medical cannabis operating from a 320,000 square foot indoor cultivation facility located in the heart of Winnipeg, Manitoba. Delivering on the company’s goal to produce better quality products at better value to consumers, Bonify’s products are available in Manitoba and Saskatchewan, with availability in additional provinces planned for the near future.
For Further Information:
Please call 1.844.586.3556 or contact Communications@Bonify.com with any media related questions or requests.